Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

NCT00291369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

456

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Interleukin-2
DRUG: Interferon alfa
DRUG: medroxyprogesterone acetate

Sponsor

Centre Leon Berard

Collaborators

[object Object]
[object Object]